# Eupraxia Pharmaceuticals Inc.: Form SC 13D, filed Nov 7, 2024

- Company: [Eupraxia Pharmaceuticals Inc.](/companies/eprx.md) (CIK 1581178)
- Form: SC 13D
- Filed: 2024-11-07
- Accepted by EDGAR: Nov 7, 2024, 16:10 ET
- Period: not reported
- Accession: 0000899140-24-001143
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1581178/000089914024001143/f80836234.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1581178/000089914024001143/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1581178/000089914024001143/f80836234.htm

Filed Nov 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000899140-24-001143. Last ingested by Listed: Nov 13, 2026, 16:45 ET. No prices; not investment advice.
